Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nenad Sarapa

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Expert Opinion on Drug Safety|September 20, 2007
Quality assessment of digital annotated ECG data from clinical trials by the FDA ECG WarehouseNenad Sarapa
Journal of Electrocardiology|July 9, 2005
Digital 12-lead Holter in the assessment of drug effects on cardiac repolarizationNenad Sarapa
Journal of Electrocardiology|August 22, 2006
Implications of methodological differences in digital electrocardiogram interval measurementFabio Badilini, Nenad Sarapa
Expert Opinion on Drug Safety|May 9, 2008
Challenges of characterizing proarrhythmic risk due to QTc prolongation induced by nonadjuvant anticancer agentsNenad Sarapa, Margaret R Britto
Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc|January 16, 2009
Automatic extraction of ECG strips from continuous 12-lead holter recordings for QT analysis at prescheduled versus optimized time pointsFabio Badilini, Martino Vaglio, Nenad Sarapa
Journal of Electrocardiology|September 20, 2008
Investigating the effect of sotalol on the repolarization intervals in healthy young individualsJean-Philippe Couderc, Meijian Zhou, Nenad Sarapa, et al.
Journal of Clinical Pharmacology|September 21, 2005
The application of accelerator mass spectrometry to absolute bioavailability studies in humans: simultaneous administration of an intravenous microdose of 14C-nelfinavir mesylate solution and oral nelfinavir to healthy volunteersNenad Sarapa, Poe-Hirr Hsyu, Graham Lappin, et al.
European Journal of Clinical Pharmacology|May 12, 2005
The effect of mild and moderate hepatic impairment on the pharmacokinetics of valdecoxib, a selective COX-2 inhibitorNenad Sarapa, Margaret R Britto, Michelle B Mainka, et al.
Clinical Cancer Drugs|November 18, 2016
Novel Antibody Therapeutics Targeting Mesothelin In Solid TumorsXiao-Yan Zhao, Babu Subramanyam, Nenad Sarapa, et al.
Journal of Clinical Pharmacology|July 28, 2007
Contrasting time- and rate-based approaches for the assessment of drug-induced QT changesFabrice Extramiana, Fabio Badilini, Nenad Sarapa, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Expert Opinion on Drug Safety|September 20, 2007
Quality assessment of digital annotated ECG data from clinical trials by the FDA ECG WarehouseNenad Sarapa
Journal of Electrocardiology|July 9, 2005
Digital 12-lead Holter in the assessment of drug effects on cardiac repolarizationNenad Sarapa
Journal of Electrocardiology|August 22, 2006
Implications of methodological differences in digital electrocardiogram interval measurementFabio Badilini, Nenad Sarapa
Expert Opinion on Drug Safety|May 9, 2008
Challenges of characterizing proarrhythmic risk due to QTc prolongation induced by nonadjuvant anticancer agentsNenad Sarapa, Margaret R Britto
Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc|January 16, 2009
Automatic extraction of ECG strips from continuous 12-lead holter recordings for QT analysis at prescheduled versus optimized time pointsFabio Badilini, Martino Vaglio, Nenad Sarapa
Journal of Electrocardiology|September 20, 2008
Investigating the effect of sotalol on the repolarization intervals in healthy young individualsJean-Philippe Couderc, Meijian Zhou, Nenad Sarapa, et al.
Journal of Clinical Pharmacology|September 21, 2005
The application of accelerator mass spectrometry to absolute bioavailability studies in humans: simultaneous administration of an intravenous microdose of 14C-nelfinavir mesylate solution and oral nelfinavir to healthy volunteersNenad Sarapa, Poe-Hirr Hsyu, Graham Lappin, et al.
European Journal of Clinical Pharmacology|May 12, 2005
The effect of mild and moderate hepatic impairment on the pharmacokinetics of valdecoxib, a selective COX-2 inhibitorNenad Sarapa, Margaret R Britto, Michelle B Mainka, et al.
Clinical Cancer Drugs|November 18, 2016
Novel Antibody Therapeutics Targeting Mesothelin In Solid TumorsXiao-Yan Zhao, Babu Subramanyam, Nenad Sarapa, et al.
Journal of Clinical Pharmacology|July 28, 2007
Contrasting time- and rate-based approaches for the assessment of drug-induced QT changesFabrice Extramiana, Fabio Badilini, Nenad Sarapa, et al.
Pageof 4